Detailed Notes on libmeldy
The FDA assessed the safety and effectiveness of atidarsagene autotemcel based on details from 37 little ones who acquired atidarsagene autotemcel in two solitary-arm, open up-label scientific trials As well as in an expanded accessibility system.[seven] Small children who gained remedy with atidarsagene autotemcel were being compared to untreated